Whitehawk (WHWK) CEO Lennon James Receives 387,914-Share Awards

What Happened Lennon David James, CEO of Whitehawk Therapeutics (WHWK), received two equity awards on September 15, 2026: 193,957 shares each (total 387,914 shares) at a $0.00 price. The awards are derivative equity grants (one award is described as restricted stock units; the other is subject to an option-style vesting schedule per the filing). This is an award/grant (not a purchase or sale) and has no upfront cash value.

Key Details

• Transaction date: 2026-09-15; Form 4 filed (amended) 2026-09-18.
• Awards: Two grants of 193,957 shares each; total = 387,914 shares; reported price $0.00.
• Instrument type: Derivative awards (RSU for one grant per footnote; the other is subject to option-style vesting language).
• Vesting notes:
  • F1 describes a standard 4‑year option vesting (25% after one year, then monthly over 36 months; Vesting Commencement Date 9/15/2026).
  • F2 clarifies each RSU represents a contingent right to one share.
  • F3 states the original Form 4 had an incorrect vesting schedule and corrects that one award vests 100% on the one‑year anniversary (Vesting Commencement Date 9/15/2026).
• Shares owned after transaction: Not specified in the provided excerpt.
• Filing status: This is an AMENDED Form 4 correcting the prior filing’s vesting information. The amended filing was submitted 3 days after the transaction date.

Context

• These are grants/awards (derivative securities). They do not represent an immediate cash purchase or sale and will only convert to stock if/when they vest and any applicable conditions are met.
• The amendment corrects vesting details from the earlier Form 4; amended filings are routine when clerical or disclosure errors are found but are important for accurately tracking insiders’ future sellable shares.
• Because these are grants rather than open‑market purchases, they are typically part of compensation packages and should be viewed as compensation-related insider activity rather than a direct market signal.